PEGylated recombinant human hyaluronidase PH20
HALO-107-201
Phase 1 small_molecule terminated
Quick answer
PEGylated recombinant human hyaluronidase PH20 for Non-small Cell Lung Cancer is a Phase 1 program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- HALOZYME THERAPEUTICS, INC.
- Indication
- Non-small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated